LindsayAnne(Magura)ReinMD

Myeloproliferative Disorder Hematology-Oncology

Physician

Dr. Rein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Duke University HospitalFellowship, Hematology and Medical Oncology, 2011 - 2014
Duke University HospitalResidency, Internal Medicine, 2008 - 2011
University of North Dakota School of Medicine and Health SciencesClass of 2008

PubMed

Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Myeloproliferative Neoplasms.
Jill Brennan-Cook, Lindsay Rein, Andrew Kuykendall, Natasha Johnson, Amie Koch
Journal of Palliative Medicine. 2024-08-20
1 citations
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.
Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, Haris Ali, Mariana Castells
Journal of the National Comprehensive Cancer Network. 2024-06-01
2 citations
Leveraging Natural Killer Cell Innate Immunity against Hematologic Malignancies: From Stem Cell Transplant to Adoptive Transfer and Beyond.
Chenyu Lin, Mitchell E Horwitz, Lindsay A M Rein
International Journal of Molecular Sciences. 2022-12-22

Lectures

Special Symposium on ASH-Supported Researchers
60th American Society of Hematology Annual Meeting - 12/3/2018
Special Symposium on ASH-Supported Researchers
60th American Society of Hematology Annual Meeting - 12/1/2018

What's Your Approach? Treating MyelofibrosisAugust 7th, 2024
OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesApril 25th, 2019
Risk Stratification in Myelofibrosis: Which Model Should You Use?July 6th, 2024